1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage

Our Firm

April 17, 2015

Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of William Tanner as a Managing Director and senior biotech research analyst.

Mr. Tanner will start work at Guggenheim in May 2015 in the firm’s New York office.

“Bill brings a wealth of biotech experience, in both investment and academic research, to our experienced and highly acclaimed healthcare team,” said Matthew Johnson, Senior Managing Director and Head of Equities at Guggenheim Securities. “Bill will join a healthcare research team that includes, on the equities side, Tony Butler in biopharmaceuticals and Louise Chen in specialty pharmaceuticals, and, on the government policy side, Rick Weissenstein in healthcare policy analysis in Washington.”

“Bill’s hiring is part of a highly-focused recent expansion of our research capabilities in such key sectors as tech-media-telecom, consumer, energy, and financial services,” said John Hervey, Senior Managing Director and Director of Research at Guggenheim Securities. “The goal is to continue to enhance our ability to help our clients achieve outstanding investment results.”

Mr. Tanner has worked nearly 20 years as a biotech analyst, including senior analyst roles at Leerink Swann and SG Cowen.

He holds a Bachelor of Science degree and a PhD in Physiology, both from Texas A&M University, as well as an MBA from Washington University’s Olin School of Business. Before embarking on his investment research career, Mr. Tanner worked as a post-doctoral research fellow at Monsanto Co. and as an NIH National Research Service Award fellow at Washington University School of Medicine.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $220 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.



November 15, 2018

Glen Santangelo to Join Guggenheim Securities as Healthcare Analyst

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Glen Santangelo will join the firm in January as a Managing Director in a planned expansion of the firm’s Healthcare Research team. Mr. Santangelo will focus on the coverage of Healthcare IT and Distribution companies in close collaboration with the growing therapeutics and services team.

Read More

October 15, 2018

Guggenheim Partners Selects Second Cohort of Network for Social Innovation

NEW YORK - Guggenheim Partners is proud to announce the selection of four non-profit organizations for the second cohort of the Network for Social Innovation. The Network for Social Innovation is a Corporate Social Responsibility venture strategy that identifies promising, early-stage organizations using innovative solutions to solve enduring social problems. It recently won WealthManagement.com’s “Corporate Social Responsibility/Diversity” Award for an Asset Manager.

Read More

October 15, 2018

Guggenheim Fourth Quarter 2018 High-Yield and Bank Loan Outlook: Strong Earnings Growth Is Masking the Rise in Borrowing Costs

NEW YORK, NY – Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today provided its Fourth Quarter 2018 High-Yield and Bank Loan Outlook.
 

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.